California State Teachers Retirement System (CalSTRS)
ARQT icon

California State Teachers Retirement System (CalSTRS)’s Arcutis Biotherapeutics ARQT Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Sell
126,258
-2,059
-2% -$48K ﹤0.01% 1328
2026
Q1 		$3.02M Buy
128,317
+25,878
+25% +$660K ﹤0.01% 1310
2025
Q4 		$2.97M Sell
102,439
-1,901
-2% -$48.7K ﹤0.01% 1207
2025
Q3 		$1.97M Buy
104,340
+6,658
+7% +$105K ﹤0.01% 1410
2025
Q2 		$1.37M Hold
97,682
– – ﹤0.01% 1566
2025
Q1 		$1.53M Sell
97,682
-862
-0.9% -$12.1K ﹤0.01% 1475
2024
Q4 		$1.37M Sell
98,544
-110
-0.1% -$1.21K ﹤0.01% 1609
2024
Q3 		$917K Sell
98,654
-2,648
-3% -$26.1K ﹤0.01% 1836
2024
Q2 		$942K Buy
101,302
+93,346
+1,173% +$844K ﹤0.01% 1788
2024
Q1 		$78.8K Sell
7,956
-5,061
-39% -$37.8K ﹤0.01% 2469
2023
Q4 		$42K Sell
13,017
-39,025
-75% -$106K ﹤0.01% 2658
2023
Q3 		$276K Sell
52,042
-2,673
-5% -$22.7K ﹤0.01% 2441
2023
Q2 		$521K Buy
54,715
+1,817
+3% +$20.2K ﹤0.01% 2286
2023
Q1 		$582K Sell
52,898
-270
-0.5% -$3.91K ﹤0.01% 2226
2022
Q4 		$787K Buy
53,168
+1,543
+3% +$27K ﹤0.01% 2059
2022
Q3 		$987K Buy
51,625
+10,932
+27% +$248K ﹤0.01% 1902
2022
Q2 		$867K Buy
40,693
+7,169
+21% +$147K ﹤0.01% 2055
2022
Q1 		$646K Sell
33,524
-2,739
-8% -$46.3K ﹤0.01% 2280
2021
Q4 		$752K Buy
36,263
+750
+2% +$14.9K ﹤0.01% 2314
2021
Q3 		$848K Sell
35,513
-2,630
-7% -$60K ﹤0.01% 2235
2021
Q2 		$1.04M Buy
38,143
+3,280
+9% +$92.4K ﹤0.01% 2194
2021
Q1 		$1.01M Buy
34,863
+3,541
+11% +$111K ﹤0.01% 2140
2020
Q4 		$881K Buy
31,322
+3,965
+14% +$97.1K ﹤0.01% 2117
2020
Q3 		$802K Buy
27,357
+13,066
+91% +$349K ﹤0.01% 1994
2020
Q2 		$432K Sell
14,291
-1,520
-10% -$43.9K ﹤0.01% 2325
2020
Q1 		$471K Buy
+15,811
New +$425K ﹤0.01% 2093

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s ARQT Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Arcutis Biotherapeutics (ARQT) stake by 1.6% in Q2 2026, selling an estimated $48K and leaving 126,258 shares worth $3.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1328.

California State Teachers Retirement System (CalSTRS) first reported a position in ARQT in Q1 2020 and has held it in 26 quarters since. 272 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 126,258 shares of Arcutis Biotherapeutics worth $3.31M as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 2,059 Arcutis Biotherapeutics shares in Q2 2026, an estimated $48K.
  • Arcutis Biotherapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #1328 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Arcutis Biotherapeutics in Q1 2020 and has held it in 26 quarters since.
  • 272 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.